| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
135 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
81 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
32 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
116 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
193 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
52 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
182 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
230 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
38 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
70 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
401 |
| 424/264.1 |
Mycoplasma |
63 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
132 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
107 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
95 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
116 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
177 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
168 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
398 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
518 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
121 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
46 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
102 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7304139 |
Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
Dec. 4, 2007 |
| 7300660 |
Abundant extracellular products and methods for their production and use |
Nov. 27, 2007 |
| 7300659 |
Enterohemorrhagic Escherichia coli vaccine |
Nov. 27, 2007 |
| 7297339 |
Rhodococcus equi mutants and vaccines comprising same |
Nov. 20, 2007 |
| 7297338 |
Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella |
Nov. 20, 2007 |
| 7291343 |
Enterococcus antigens and vaccines |
Nov. 6, 2007 |
| 7291325 |
Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins |
Nov. 6, 2007 |
| 7288261 |
Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
Oct. 30, 2007 |
| 7285289 |
Nanoparticle vaccines |
Oct. 23, 2007 |
| 7285276 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Oct. 23, 2007 |
| 7279170 |
32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
Oct. 9, 2007 |
| 7279169 |
Mucosal DTPa vaccines |
Oct. 9, 2007 |
| 7279168 |
Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof |
Oct. 9, 2007 |
| 7276350 |
Method for diagnosing infectious diseases |
Oct. 2, 2007 |
| 7273722 |
Neurotoxins with enhanced target specificity |
Sep. 25, 2007 |
| 7273611 |
Proteinase K resistant surface protein of neisseria meningitidis |
Sep. 25, 2007 |
| 7273602 |
Immunotherapy for humans |
Sep. 25, 2007 |
| 7270827 |
Multivalent streptococcal vaccine compositions and methods for use |
Sep. 18, 2007 |
| 7264815 |
Process for producing a recombinant protein in a mycobacterium host plasmid pJAM2 |
Sep. 4, 2007 |
| 7262271 |
Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
Aug. 28, 2007 |
| 7261900 |
Recombinant modified Bacillus anthracis protective antigen for use in vaccines |
Aug. 28, 2007 |
| 7261899 |
Method of producing thy A-strains of Vibrio cholerae, such strains and their use |
Aug. 28, 2007 |
| 7259239 |
Lipopolysaccharide .alpha.-2,3 sialyltransferase of campylobacter jejuni and its uses |
Aug. 21, 2007 |
| 7258863 |
Heterologous protection induced by immunization with invaplex vaccine |
Aug. 21, 2007 |
| 7256265 |
Streptococcal C5a peptidase vaccine |
Aug. 14, 2007 |
| 7255867 |
Vaccine |
Aug. 14, 2007 |
| 7255863 |
Group A streptococcal vaccines |
Aug. 14, 2007 |
| 7252828 |
Polysaccharide vaccine for staphylococcal infections |
Aug. 7, 2007 |
| 7247308 |
Streptococcus pyogenes antigens |
Jul. 24, 2007 |
| 7247307 |
Vaccines against Escherichia coli O157 infection |
Jul. 24, 2007 |
| 7247306 |
Bacteria strain and bacteriocin produced therefrom |
Jul. 24, 2007 |
| 7241449 |
Transferrin receptor genes of moraxella |
Jul. 10, 2007 |
| 7241441 |
Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities |
Jul. 10, 2007 |
| 7238359 |
Antigen ORF Rv2430c and a method thereof |
Jul. 3, 2007 |
| 7238345 |
Recombinant microorganism expressing meningococcal class 1 outer membrane protein |
Jul. 3, 2007 |
| 7235243 |
Immunological combination compositions and methods |
Jun. 26, 2007 |
| 7232569 |
Type III secretion pathway in aeromonas salmonicida, and uses therefor |
Jun. 19, 2007 |
| 7229645 |
Spray freeze-dried compositions |
Jun. 12, 2007 |
| 7226588 |
Non-toxic mutants of pathogenic gram-negative bacteria |
Jun. 5, 2007 |
| 7223836 |
Peptides for chlamydophila pneumoniae vaccine and diagnosis |
May. 29, 2007 |
| 7223412 |
Staphylococcal enterotoxin SEC-SER, expression vector and host cell, production method thereof, and manufacturing method of vaccine |
May. 29, 2007 |
| 7220418 |
Delivery of trefoil peptides |
May. 22, 2007 |
| 7217791 |
Compositions and methods for treating or preventing pneumococcal infection |
May. 15, 2007 |
| 7217420 |
Mycoplasma gallisepticum formulation |
May. 15, 2007 |
| 7214380 |
Adjuvant therapy |
May. 8, 2007 |
| 7211263 |
Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella |
May. 1, 2007 |
| 7211261 |
Stable liquid formulations of botulinum toxin |
May. 1, 2007 |
| 7208574 |
Host receptor for pathogenic bacteria |
Apr. 24, 2007 |
| 7208166 |
Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
Apr. 24, 2007 |
| 7204993 |
Streptococcus agalactiae vaccine |
Apr. 17, 2007 |
|
|
|
